Medicines Co. (MDCO) Reports Q2 EPS of $2.51

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. MRVL
7. ABBV
8. CL
9. TFII
10. ORCL

Go back to Medicines Co. (MDCO) Reports Q2 EPS of $2.51

The Medicines Company (MDCO) PT Raised to $55 at Guggenheim; Sees Multiple Avenues to Unlock Value

July 27, 2016 10:10 AM EDT

Guggenheim analyst Louise Chen reiterated a Buy rating and lifted her price target on The Medicines Company (NASDAQ: MDCO) to $55.00 (from $45.00) following Q2 results. The analyst sees multiple avenue to unlock value ahead of potential catalysts in 2016+.

Chen commented, "2Q16 results underscore our positive investment thesis, in our view, because MDCO continues to advance its pipeline and has multiple strategic options available... More